sugammadex zentiva 100 mg/ml injekčný roztok
zentiva, k.s., Česká republika - sugamadex - 19 - antidota, detoxicantia
sugammadex juta
juta pharma gmbh, nemecko - sugamadex - 19 - antidota, detoxicantia
sugammadex kalceks 100 mg/ml injekčný roztok
as kalceks, lotyšsko - sugamadex - 19 - antidota, detoxicantia
sugammadex aptapharma 100 mg/ml injekčný roztok
apta medica internacional d.o.o., slovinsko - sugamadex - 19 - antidota, detoxicantia
sugammadex reddy 100 mg/ml injekčný roztok
reddy holding gmbh, nemecko - sugamadex - 19 - antidota, detoxicantia
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulárna blokáda - všetky ostatné terapeutické produkty - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
rocuronium bromide hameln 10 mg/ml injekčný/infúzny roztok
hameln pharma gmbh, nemecko - rokuróniumbromid - 63 - myorelaxantia
rocuronium fresenius kabi 10 mg/ml
fresenius kabi s.r.o., Česká republika - rokuróniumbromid - 63 - myorelaxantia
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromuskulárna blokáda - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulárna blokáda - všetky ostatné terapeutické produkty - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.